{"id":39105,"date":"2017-05-16T06:55:41","date_gmt":"2017-05-16T10:55:41","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=39105"},"modified":"2017-05-16T06:17:24","modified_gmt":"2017-05-16T10:17:24","slug":"pdl-biopharma-inc-nasdaqpdli-and-lensar-inc-on-the-final-stages-of-the-strategic-financial-restructuring-of-lensar","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/pdl-biopharma-inc-nasdaqpdli-and-lensar-inc-on-the-final-stages-of-the-strategic-financial-restructuring-of-lensar-39105","title":{"rendered":"PDL BioPharma Inc (NASDAQ:PDLI) And LENSAR\u00ae, Inc On The Final Stages Of The Strategic Financial Restructuring Of LENSAR"},"content":{"rendered":"<p style=\"text-align: justify;\">LENSAR, Inc happens to be one of the global leaders focusing on establishing the next generation femtosecond laser technology for refractive cataract surgery and in close collaboration with <strong>PDL BioPharma Inc (NASDAQ:PDLI)<\/strong> they have made the much awaited for announcement.<\/p>\n<p style=\"text-align: justify;\">The news striking the airwaves is that the company is on the finalizing stages of financial restructuring\u00a0and at this point in time it is important to also mention the court-approved exit plan\u00a0that effective on May 11, 2017.<\/p>\n<p style=\"text-align: justify;\">As a part of the bigger picture, sources reveal that indeed PDL will be moving ahead to actually convert a large fraction of its debt to an equity ownership position. As a matter of fact, the stage is already prepared where\u00a0LENSAR is set to become a wholly-owned subsidiary of PDL and in other news it has been outlined that PDL will be seeking to start on its consolidation plan to the financial statements associated with LENSAR.<\/p>\n<p style=\"text-align: justify;\">Some of the top planning and financial executives have come forward to say that with the debt reduced by a large chunk, LENSAR\u2019s balance sheet will in a major way be strengthened and the matter about PDL bearing the new ownership \u201cbadge\u201d is something that can ion no way be taken for a ride.<\/p>\n<p style=\"text-align: justify;\">According to the company\u2019s insiders, LENSAR is best placed to give a major lift to its future development as well as to the continued leadership; of course in the femtosecond laser assisted refractive cataract surgery sector. The bankruptcy court in Wilmington, Delaware was the one that went ahead to confirm the reorganization of agreement.<\/p>\n<p style=\"text-align: justify;\">The chief executive officer of LENSAR, Nicholas Curtis while addressing a press conference said, &#8220;This process has been necessary to achieve the full potential of our femtosecond technology and continue to deliver best-in-class service to our customers and their refractive cataract patients. Importantly, our focused efforts have achieved this successful end-goal on schedule.\u201d<\/p>\n<p style=\"text-align: justify;\">Curtis finalized by speaking on behalf of the company by stating that they were extremely excited with the outcome and that they were optimistic that their partnership with PDL will be strengthened in the course of time.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>LENSAR, Inc happens to be one of the global leaders focusing on establishing the next generation femtosecond laser technology for refractive cataract surgery and in [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":39112,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[5203,9306,5202],"stock_ticker":[],"class_list":["post-39105","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-nasdaqpdli","tag-pdl-biopharma-inc","tag-pdl-biopharma-inc-nasdaqpdli","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>PDL BioPharma Inc (NASDAQ:PDLI) And LENSAR\u00ae, Inc On The Final Stages Of The Strategic Financial Restructuring Of LENSAR - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/pdl-biopharma-inc-nasdaqpdli-and-lensar-inc-on-the-final-stages-of-the-strategic-financial-restructuring-of-lensar-39105\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"PDL BioPharma Inc (NASDAQ:PDLI) And LENSAR\u00ae, Inc On The Final Stages Of The Strategic Financial Restructuring Of LENSAR - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"LENSAR, Inc happens to be one of the global leaders focusing on establishing the next generation femtosecond laser technology for refractive cataract surgery and in [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/pdl-biopharma-inc-nasdaqpdli-and-lensar-inc-on-the-final-stages-of-the-strategic-financial-restructuring-of-lensar-39105\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2017-05-16T10:55:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/05\/39111-maxresdefault.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Donna Fago\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Donna Fago\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pdl-biopharma-inc-nasdaqpdli-and-lensar-inc-on-the-final-stages-of-the-strategic-financial-restructuring-of-lensar-39105#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pdl-biopharma-inc-nasdaqpdli-and-lensar-inc-on-the-final-stages-of-the-strategic-financial-restructuring-of-lensar-39105\"},\"author\":{\"name\":\"Donna Fago\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84\"},\"headline\":\"PDL BioPharma Inc (NASDAQ:PDLI) And LENSAR\u00ae, Inc On The Final Stages Of The Strategic Financial Restructuring Of LENSAR\",\"datePublished\":\"2017-05-16T10:55:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pdl-biopharma-inc-nasdaqpdli-and-lensar-inc-on-the-final-stages-of-the-strategic-financial-restructuring-of-lensar-39105\"},\"wordCount\":374,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pdl-biopharma-inc-nasdaqpdli-and-lensar-inc-on-the-final-stages-of-the-strategic-financial-restructuring-of-lensar-39105#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/05\/39111-maxresdefault.jpg\",\"keywords\":[\"NASDAQ:PDLI\",\"PDL BioPharma Inc\",\"PDL BioPharma Inc (NASDAQ:PDLI)\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/pdl-biopharma-inc-nasdaqpdli-and-lensar-inc-on-the-final-stages-of-the-strategic-financial-restructuring-of-lensar-39105#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pdl-biopharma-inc-nasdaqpdli-and-lensar-inc-on-the-final-stages-of-the-strategic-financial-restructuring-of-lensar-39105\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pdl-biopharma-inc-nasdaqpdli-and-lensar-inc-on-the-final-stages-of-the-strategic-financial-restructuring-of-lensar-39105\",\"name\":\"PDL BioPharma Inc (NASDAQ:PDLI) And LENSAR\u00ae, Inc On The Final Stages Of The Strategic Financial Restructuring Of LENSAR - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pdl-biopharma-inc-nasdaqpdli-and-lensar-inc-on-the-final-stages-of-the-strategic-financial-restructuring-of-lensar-39105#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pdl-biopharma-inc-nasdaqpdli-and-lensar-inc-on-the-final-stages-of-the-strategic-financial-restructuring-of-lensar-39105#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/05\/39111-maxresdefault.jpg\",\"datePublished\":\"2017-05-16T10:55:41+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pdl-biopharma-inc-nasdaqpdli-and-lensar-inc-on-the-final-stages-of-the-strategic-financial-restructuring-of-lensar-39105#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/pdl-biopharma-inc-nasdaqpdli-and-lensar-inc-on-the-final-stages-of-the-strategic-financial-restructuring-of-lensar-39105\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pdl-biopharma-inc-nasdaqpdli-and-lensar-inc-on-the-final-stages-of-the-strategic-financial-restructuring-of-lensar-39105#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/05\/39111-maxresdefault.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/05\/39111-maxresdefault.jpg\",\"width\":1920,\"height\":1080},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pdl-biopharma-inc-nasdaqpdli-and-lensar-inc-on-the-final-stages-of-the-strategic-financial-restructuring-of-lensar-39105#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"PDL BioPharma Inc (NASDAQ:PDLI) And LENSAR\u00ae, Inc On The Final Stages Of The Strategic Financial Restructuring Of LENSAR\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84\",\"name\":\"Donna Fago\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg\",\"caption\":\"Donna Fago\"},\"description\":\"I believe in writing content Informing investors with the knowledge they need to invest better today- I have been following the markets for many years and was asked to join the team at WallStreetPR.com recently due to my passion for the markets.\",\"sameAs\":[\"http:\/\/www.WallStreetPR.com\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/darcie-fago\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"PDL BioPharma Inc (NASDAQ:PDLI) And LENSAR\u00ae, Inc On The Final Stages Of The Strategic Financial Restructuring Of LENSAR - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/pdl-biopharma-inc-nasdaqpdli-and-lensar-inc-on-the-final-stages-of-the-strategic-financial-restructuring-of-lensar-39105","og_locale":"en_US","og_type":"article","og_title":"PDL BioPharma Inc (NASDAQ:PDLI) And LENSAR\u00ae, Inc On The Final Stages Of The Strategic Financial Restructuring Of LENSAR - Wall Street PR","og_description":"LENSAR, Inc happens to be one of the global leaders focusing on establishing the next generation femtosecond laser technology for refractive cataract surgery and in [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/pdl-biopharma-inc-nasdaqpdli-and-lensar-inc-on-the-final-stages-of-the-strategic-financial-restructuring-of-lensar-39105","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2017-05-16T10:55:41+00:00","og_image":[{"width":1920,"height":1080,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/05\/39111-maxresdefault.jpg","type":"image\/jpeg"}],"author":"Donna Fago","twitter_misc":{"Written by":"Donna Fago","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pdl-biopharma-inc-nasdaqpdli-and-lensar-inc-on-the-final-stages-of-the-strategic-financial-restructuring-of-lensar-39105#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pdl-biopharma-inc-nasdaqpdli-and-lensar-inc-on-the-final-stages-of-the-strategic-financial-restructuring-of-lensar-39105"},"author":{"name":"Donna Fago","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84"},"headline":"PDL BioPharma Inc (NASDAQ:PDLI) And LENSAR\u00ae, Inc On The Final Stages Of The Strategic Financial Restructuring Of LENSAR","datePublished":"2017-05-16T10:55:41+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pdl-biopharma-inc-nasdaqpdli-and-lensar-inc-on-the-final-stages-of-the-strategic-financial-restructuring-of-lensar-39105"},"wordCount":374,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pdl-biopharma-inc-nasdaqpdli-and-lensar-inc-on-the-final-stages-of-the-strategic-financial-restructuring-of-lensar-39105#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/05\/39111-maxresdefault.jpg","keywords":["NASDAQ:PDLI","PDL BioPharma Inc","PDL BioPharma Inc (NASDAQ:PDLI)"],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/pdl-biopharma-inc-nasdaqpdli-and-lensar-inc-on-the-final-stages-of-the-strategic-financial-restructuring-of-lensar-39105#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pdl-biopharma-inc-nasdaqpdli-and-lensar-inc-on-the-final-stages-of-the-strategic-financial-restructuring-of-lensar-39105","url":"https:\/\/cablemanpro.com\/wallstreetpr\/pdl-biopharma-inc-nasdaqpdli-and-lensar-inc-on-the-final-stages-of-the-strategic-financial-restructuring-of-lensar-39105","name":"PDL BioPharma Inc (NASDAQ:PDLI) And LENSAR\u00ae, Inc On The Final Stages Of The Strategic Financial Restructuring Of LENSAR - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pdl-biopharma-inc-nasdaqpdli-and-lensar-inc-on-the-final-stages-of-the-strategic-financial-restructuring-of-lensar-39105#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pdl-biopharma-inc-nasdaqpdli-and-lensar-inc-on-the-final-stages-of-the-strategic-financial-restructuring-of-lensar-39105#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/05\/39111-maxresdefault.jpg","datePublished":"2017-05-16T10:55:41+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pdl-biopharma-inc-nasdaqpdli-and-lensar-inc-on-the-final-stages-of-the-strategic-financial-restructuring-of-lensar-39105#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/pdl-biopharma-inc-nasdaqpdli-and-lensar-inc-on-the-final-stages-of-the-strategic-financial-restructuring-of-lensar-39105"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pdl-biopharma-inc-nasdaqpdli-and-lensar-inc-on-the-final-stages-of-the-strategic-financial-restructuring-of-lensar-39105#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/05\/39111-maxresdefault.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/05\/39111-maxresdefault.jpg","width":1920,"height":1080},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pdl-biopharma-inc-nasdaqpdli-and-lensar-inc-on-the-final-stages-of-the-strategic-financial-restructuring-of-lensar-39105#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"PDL BioPharma Inc (NASDAQ:PDLI) And LENSAR\u00ae, Inc On The Final Stages Of The Strategic Financial Restructuring Of LENSAR"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84","name":"Donna Fago","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg","caption":"Donna Fago"},"description":"I believe in writing content Informing investors with the knowledge they need to invest better today- I have been following the markets for many years and was asked to join the team at WallStreetPR.com recently due to my passion for the markets.","sameAs":["http:\/\/www.WallStreetPR.com"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/darcie-fago"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/39105","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=39105"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/39105\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/39112"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=39105"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=39105"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=39105"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=39105"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}